SenzaGen presenterar stark GARD®skin-data på världens största toxikologikonferens tillsammans med ledande industripartners
SenzaGen to present strong GARD®skin data at the world’s largest toxicology conference together with leading industry partners
Growing interest in non-animal respiratory allergy testing – GARD®air data presented by industry leaders
Ökat intresse för djurfri testning av luftvägsallergi – GARD®air-data presenteras av branschledande aktörer
SenzaGen genomför en riktad nyemission om cirka 17,5 MSEK till den institutionella investeraren Eiffel Investment Group
SenzaGen carries out a directed issue of approximately SEK 17.5 million to the institutional investor Eiffel Investment Group
